Levitas x Hinnao | NAD+

Why choose HINNAO NAD+ (Nicotinamide Adenine Dinucleotide)
Until Now NAD+ has only been available in IV drip therapy clinics, due to the molecule not being stable.Using clinically proven high-stability liposomes, as a delivery mechanism HINNAO NAD+ absorbs instantly via the mucous membrane crossing the blood brain barrier.

Low NAD+ levels are associated with ageing and being more prone to chronic diseases such as diabetes, heart disease, Alzheimer’s disease and vision loss.

Using clinically proven high-stability liposomes as a delivery mechanism, HINNAO NAD+ absorbs instantly via the mucous membrane.

Absorption in Seconds

Our patented HINNAO technology allows us to use lipid particles to absorb via the mucous membrane which means 85% of each dose is absorbed within 60 seconds.